HYBRIGENICS (EPA:ALHYG) | WebDisclosure

BRIEF

published on 06/25/2026 at 18:20, 2 days 2 hours ago

Pims Technology: Towards Optimizing Cancer Treatments

Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF

published on 06/25/2026 at 18:20, 2 days 2 hours ago

Pims Technology : Vers une Optimisation des Traitements Oncologiques

Oncologie Médecine Personnalisée Technologie PIMS Évaluation Thérapeutique Implantation Européenne
PRESS RELEASE

published on 06/25/2026 at 18:15, 2 days 3 hours ago

PIMS TECHNOLOGY : UNE TECHNOLOGIE QUI VISE A EVITER DES MILLIARDS D'EUROS DE TRAITEMENTS INEFFICACES EN ONCOLOGIE
Publication du Groupe Aton sur sa filiale Pims Technology et sa technologie d'évaluation de la réponse des patients aux traitements grâce à leur empreinte moléculaire

Oncologie Médecine Personnalisée Groupe Aton PIMS Technology Empreinte Moléculaire
BRIEF

published on 05/07/2026 at 10:05, 1 month 20 days ago

Aton Group is organizing a webinar for shareholders and investors on May 12, 2026

Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF

published on 05/07/2026 at 10:05, 1 month 20 days ago

Groupe Aton organise un webinaire pour actionnaires et investisseurs le 12 mai 2026

Actionnaires Biotechnologie Webinaire Groupe Aton Résultats 2025
PRESS RELEASE

published on 05/07/2026 at 10:00, 1 month 20 days ago

WEBINAIRE ATON DESTINÉ AUX ACTIONNAIRES ET INVESTISSEURS INDIVIDUELS MARDI 12 MAI 2026 À 18H00
Le Groupe Aton, spécialisé en sciences médicales, organise une visioconférence pour présenter les résultats 2025 et perspectives. Actionnaires et investisseurs individuels invités. Inscription en ligne

Visioconférence Investisseurs Groupe Aton Sciences Médicales Résultats 2025
BRIEF

published on 04/28/2026 at 18:05, 1 month 29 days ago

Résultats annuels 2025 : Groupe Aton

Partenariats Stratégiques Expansion Commerciale Groupe Aton Biotechnologies Résultats 2025
BRIEF

published on 04/28/2026 at 18:05, 1 month 29 days ago

2025 Annual Results: Aton Group

Strategic Partnerships Biotechnology Business Expansion 2025 Results Aton Group
PRESS RELEASE

published on 04/28/2026 at 18:00, 1 month 29 days ago

RESULTATS ANNUELS 2025
Le Groupe Aton, spécialisé dans les sciences médicales, annonce ses résultats consolidés pour 2025, marqués par une transformation stratégique. Perspectives axées sur le développement commercial et la recherche de revenus récurrents

Revenus Récurrents Développement Commercial Résultats Consolidés Groupe Aton Sciences Médicales
BRIEF

published on 04/23/2026 at 18:05, 2 months 4 days ago

B Cell Design innove face à la pénurie de réactifs diagnostics

Diagnostic In Vitro Groupe Aton Anticorps Monoclonaux Technologie Brevetée B Cell Design

1 2 ... 7

Published on 06/27/2026 at 16:50, 4 hours 28 minutes ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 19 hours 38 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 21 hours 18 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 22 hours 18 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 22 hours 28 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 21 hours 12 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 21 hours 13 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 21 hours 42 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 21 hours 42 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 21 hours 50 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 1 day 3 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 1 day 3 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 1 day 3 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 1 day 6 hours ago

Safran information
Published on 06/26/2026 at 14:44, 1 day 6 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News